185 related articles for article (PubMed ID: 30944204)
21. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
Liu J; Liu Z; Zhang X; Gong T; Yao D
BMC Cancer; 2019 Mar; 19(1):227. PubMed ID: 30866865
[TBL] [Abstract][Full Text] [Related]
22. PDPN is a prognostic biomarker and correlated with immune infiltrating in gastric cancer.
Hu L; Zhang P; Sun W; Zhou L; Chu Q; Chen Y
Medicine (Baltimore); 2020 May; 99(19):e19957. PubMed ID: 32384443
[TBL] [Abstract][Full Text] [Related]
23. Immune infiltration profiling in gastric cancer and their clinical implications.
Ren F; Zhao Q; Zhao M; Zhu S; Liu B; Bukhari I; Zhang K; Wu W; Fu Y; Yu Y; Tang Y; Zheng P; Mi Y
Cancer Sci; 2021 Sep; 112(9):3569-3584. PubMed ID: 34251747
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.
Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS
Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752
[TBL] [Abstract][Full Text] [Related]
25. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
[TBL] [Abstract][Full Text] [Related]
26. Pan-cancer analysis reveals signal transducer and activator of transcription (STAT) gene family as biomarkers for prognostic prediction and therapeutic guidance.
Cheng M; Liu Y; Guo Y; Li M; Xian S; Qin H; Yang Y; Qian W; Tang J; Lu Y; Yao Y; Zhang M; Jin M; Xu L; Huang R; Xu D
Front Genet; 2023; 14():1120500. PubMed ID: 36968603
[No Abstract] [Full Text] [Related]
27. Impact of chemokine receptor CXCR3 on tumor-infiltrating lymphocyte recruitment associated with favorable prognosis in advanced gastric cancer.
Li K; Zhu Z; Luo J; Fang J; Zhou H; Hu M; Maskey N; Yang G
Int J Clin Exp Pathol; 2015; 8(11):14725-32. PubMed ID: 26823797
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.
Kawazoe A; Kuwata T; Kuboki Y; Shitara K; Nagatsuma AK; Aizawa M; Yoshino T; Doi T; Ohtsu A; Ochiai A
Gastric Cancer; 2017 May; 20(3):407-415. PubMed ID: 27629881
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).
Machado I; López-Guerrero JA; Scotlandi K; Picci P; Llombart-Bosch A
Virchows Arch; 2018 May; 472(5):815-824. PubMed ID: 29445891
[TBL] [Abstract][Full Text] [Related]
30. Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer.
Shen JX; Liu J; Li GW; Huang YT; Wu HT
Oncotarget; 2016 May; 7(18):25340-9. PubMed ID: 27015121
[TBL] [Abstract][Full Text] [Related]
31. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
[TBL] [Abstract][Full Text] [Related]
32. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
33. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
34. Systematic Characterization of Prognostic Values of Peroxiredoxin Family in Gastric Cancer.
Xu R; Pan J; Mei J; Zhang Q
Biomed Res Int; 2020; 2020():3948183. PubMed ID: 32382548
[TBL] [Abstract][Full Text] [Related]
35. Mining database for the therapeutic targets and prognostic biomarkers among STAT family in glioblastoma.
Li C; Zhou Y; Deng H; Ye Y; Zhao S; Liang S; Cai S; Lin J; Tang Y; Wu Y
Cancer Biomark; 2021; 30(2):179-191. PubMed ID: 33104022
[TBL] [Abstract][Full Text] [Related]
36. Mining topoisomerase isoforms in gastric cancer.
Hou G; Deng J; You X; Chen J; Jiang Y; Qian T; Bi Y; Song B; Xu Y; Yang X
Gene; 2020 Sep; 754():144859. PubMed ID: 32535049
[TBL] [Abstract][Full Text] [Related]
37. An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis.
Wang Y; He L; Cheng Y
Clin Transl Oncol; 2018 Feb; 20(2):212-220. PubMed ID: 28681313
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of Excision Repair Cross-Complementing mRNA Expression in Gastric Cancer.
Luo SS; Liao XW; Zhu XD
Biomed Res Int; 2018; 2018():6204684. PubMed ID: 30417012
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
[TBL] [Abstract][Full Text] [Related]
40. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
